United Therapeutics
UTHR
UTHR
367 hedge funds and large institutions have $5.48B invested in United Therapeutics in 2018 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 133 increasing their positions, 127 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 127
2% less funds holding
Funds holding: 374 → 367 (-7)
12% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 34
Holders
367
Holding in Top 10
6
Calls
$28.9M
Puts
$25.7M
Top Buyers
| 1 | +$49.6M | |
| 2 | +$47.1M | |
| 3 | +$37.8M | |
| 4 |
AC
Armistice Capital
New York
|
+$37.3M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$30.1M |
Top Sellers
| 1 | -$74.4M | |
| 2 | -$60.2M | |
| 3 | -$42M | |
| 4 |
JP Morgan Chase
New York
|
-$31.2M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$13.8M |